The analysis of DEGs, including the downregulation of SLC4A1 and EPB42 and the upregulation of PIP4K2A, highlighted potential molecular mechanisms contributing to SLE pathogenesis, particularly in antiviral pathways. The gene discussed is PIP4K2A; the disease is systemic lupus erythematosus.